Ovid Therapeutics Vs. Aritzia Industry Stock Comparison

Buy

63

OVID
Ovid Therapeutics

Last Price:

1.23

Seasonality Move:

-0.69%

Sell

40

ATZAF
Aritzia

Last Price:

33.13

Seasonality Move:

14.48%

Buy

63

Ovid Therapeutics (OVID) is a Buy

Is Ovid Therapeutics a Buy, Sell or Hold?

The current Ovid Therapeutics [OVID] share price is $1.24. The Score for OVID is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
OVID is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

40

Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

The current Aritzia [ATZAF] share price is $32.80. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OVID Stock Price Chart

What is Ovid Therapeutics's stock price today?

The Ovid Therapeutics share price today is $1.24
The current trend is moderately bullish and OVID is experiencing selling pressure, which indicates risk of future bearish movement.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

The Aritzia share price today is $32.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATZAF is experiencing buying pressure, which is a positive indicator for future bullish movement.

OVID Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.04	Buy
Relative Strength Index (14 RSI):	53.74	Buy
Chaikin Money Flow:	-238192	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.12 - 1.26)	Buy
Bollinger Bands (100):	(0.92 - 1.22)	Buy

ATZAF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.9	Sell
Relative Strength Index (14 RSI):	50.73	Buy
Chaikin Money Flow:	7616	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(30.43 - 34.95)	Buy
Bollinger Bands (100):	(30.1 - 35.52)	Sell

OVID Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.26	Sell
20-day SMA:	1.21	Buy
50-day SMA:	1.16	Buy
200-day SMA:	2.12	Sell
8-day EMA:	1.27	Sell
20-day EMA:	1.22	Buy
50-day EMA:	1.2	Buy
200-day EMA:	1.86	Sell

ATZAF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	31.79	Buy
20-day SMA:	31.82	Buy
50-day SMA:	34.06	Sell
200-day SMA:	29.5	Buy
8-day EMA:	31.34	Buy
20-day EMA:	32.22	Buy
50-day EMA:	33.01	Sell
200-day EMA:	29.97	Buy

Ovid Therapeutics Earnings Growth & OVID Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.24 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Ovid Therapeutics Technical Analysis

	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12
	Oct			Nov
	30	31	01	04	05	06	07	08	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12
	Oct			Nov
	30	31	01	04	05	06	07	08	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):